ReviewThe British journal of ophthalmology2007
Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies.
Review in The British journal of ophthalmology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 58 citations in OpenAlex.
- Analytical study of influence of polymorphisms of VEGF+936T/C, ACE ID, TNF308G/A, and GSTP1 genes on retinopathy of prematurity progression/regression.Indian journal of ophthalmology · 2026Article
- Management of retinopathy of prematurity in a tertiary referral neonatal intensive care unit: Treatment rates and the impact of outsourcing laser therapy.Acta ophthalmologica · 2026Observational
- Identification of genetic factors underlying severe retinopathy of prematurity in preterm infants.Molecular vision · 2025Article
- Genetic Polymorphisms of Vascular Endothelial Growth Factor in Neonatal Pathologies: A Systematic Search and Narrative Synthesis of the Literature.Children (Basel, Switzerland) · 2023Review
- The Need to Address Sex as a Biological Variable in Neonatal Clinical Studies.The Journal of pediatrics · 2023Article
- Microglia refine developing retinal astrocytic and vascular networks through the complement C3/C3aR axis.Development (Cambridge, England) · 2023Article
- Systemic Cytokines in Retinopathy of Prematurity.Journal of personalized medicine · 2023Review
- Research hotspots and trends in retinopathy of prematurity from 2003 to 2022: a bibliometric analysis.Frontiers in pediatrics · 2023Article
- The benefits, limitations and opportunities of preclinical models for neonatal drug development.Disease models & mechanisms · 2022Review
- Short-term outcomes of Jewish and Arab preterms: a population-based comparison.Journal of perinatology : official journal of the California Perinatal Association · 2021Article
- Case control study of risk factors and ophthalmological outcomes of very low birth weight infants with Type 1 retinopathy of prematurity.Singapore medical journal · 2020Article
- Dyslipidemia in retinal metabolic disorders.EMBO molecular medicine · 2019Review
- Influence of polymorphisms inInternational journal of ophthalmology · 2018Article
- Risk factors for retinopathy of prematurity: insights from outlier infants.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2014Article
- Inhibition of retinopathy of prematurity in rat by intravitreal injection of sorafenib.International journal of ophthalmology · 2014Article
- Genetic polymorphisms of vascular endothelial growth factor and risk for retinopathy of prematurity in South of Iran.Molecular biology reports · 2013Article
- Genetic variants of FZD4 and LRP5 genes in patients with advanced retinopathy of prematurity.Molecular vision · 2013Article
- The genetic control of avascular area in mouse oxygen-induced retinopathy.Molecular vision · 2012Article
- Genetic screening of Wnt signaling factors in advanced retinopathy of prematurity.Molecular vision · 2010Article
- Genetic susceptibility to advanced retinopathy of prematurity (ROP).Journal of biomedical science · 2010Review
Corrections and comments
- Commented on by
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite advances in management and treatment, retinopathy of prematurity remains a major cause of childhood blindness. Evidence for a genetic basis for susceptibility to retinopathy of prematurity is examined, including the influences of sex, ethnicity, and ocular pigmentation. The role of polymorphisms is explored in the genes for vascular endothelial growth factor and insulin-like growth factor-1, and of mutations in the Norrie disease gene. Insights into the genetic basis of retinopathy of prematurity provided by the animal model of oxygen induced retinopathy are examined. Evidence for a genetic component for susceptibility to retinopathy of prematurity is strong, although the molecular identity of the gene or genes involved remains uncertain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.